- Report
- March 2024
- 134 Pages
Asia Pacific
From €1365EUR$1,500USD£1,160GBP
- Report
- May 2024
- 67 Pages
South Africa
From €2048EUR$2,250USD£1,739GBP
- Report
- April 2022
- 25 Pages
United States
- Book
- June 2022
- 800 Pages
From €150EUR$165USD£128GBP
- Training
- 60 Minutes
Global
From €137EUR$150USD£116GBP
- Report
- February 2024
- 283 Pages
Global
From €2275EUR$2,499USD£1,932GBP
€3249EUR$3,570USD£2,760GBP
- Book
- April 2025
- 1024 Pages
- Book
- July 2021
- 480 Pages
- Book
- May 2021
- 608 Pages
- Book
- January 2021
- 160 Pages
- Book
- May 2018
- 872 Pages
- Book
- December 2017
- 1096 Pages
- Book
- November 2015
- 544 Pages
- Book
- January 2015
- 304 Pages
- Book
- April 2011
- 664 Pages
€1484EUR$1,747USD£1,305GBP
€1575EUR$1,854USD£1,385GBP

Attention Deficit Hyperactivity Disorder (ADHD) is a mental health disorder characterized by difficulty paying attention, hyperactivity, and impulsivity. It is most commonly diagnosed in children, but can persist into adulthood. Treatment for ADHD typically includes medication, psychotherapy, and lifestyle changes.
The ADHD market is a subset of the larger mental health market, which is estimated to be worth billions of dollars. The ADHD market is expected to grow in the coming years due to increased awareness and diagnosis of the disorder.
Several companies are involved in the ADHD market, including pharmaceutical companies that produce medications for the disorder, as well as companies that provide psychotherapy and lifestyle interventions. Examples of these companies include Shire, Novartis, and Otsuka Pharmaceuticals. Show Less Read more